German government doesn’t know how much cannabis sold in 2019, can’t estimate 2020 demand

The German federal government admitted that it doesn’t know how much medical cannabis was sold in the country in 2019.

The importance of vetting cannabis vape hardware suppliers & testing vaporizer components

Even before federal health officials singled out the additive vitamin E acetate for the rash of vaping illnesses sweeping the country, cannabis companies scrambled to investigate whether vape cartridges, batteries and other components were to blame.

Australia expedites review of medical cannabis product Epidiolex

The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another.

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana.

2020 will demonstrate whether cannabis operators can transfer Colombia into marijuana powerhouse

Cannabis companies are wagering hundreds of millions of dollars on Colombia’s emerging cannabis industry, betting the Latin American country will become a major production and export hub.
But 2019 wasn’t the year in which these businesses began churning out medical cannabis products.

The future of the medical marijuana industry: Q&A with Andrea Small-Howard, chief science officer at GB Sciences

Andrea Small-Howard has a unique view into how the medical side of the cannabis space is evolving.

She’s the chief science officer at GB Sciences, a Las Vegas-based marijuana company pursuing two strategies – one recreational, and the other aiming for U.S. Food and Drug Administration (FDA) approval of its medical cannabis products.